NIH-funded research P01 program project

T-Cell Signals in Neonatal Heart Regeneration

Official title: T-Cell-Mediated Inflammatory Response in Neonatal Heart Regeneration

Funded at University of Arizona · NIH-11417875 · Data updated 2026-11-12

This project explores how a specific immune pathway involving CD4+ T helper 2 cells may help the neonatal heart repair itself after injury in mouse models, with potential implications for human heart healing.

More Inflammatory Response research and trials

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startApril 5, 2023
Project endMarch 31, 2028
Funding year2026
Award (this year)$279,391
NIH project number5P01HL160488-04
Project IDNIH-11417875 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable at this stage; findings may inform future studies in patients with heart injury.

Less likely to help

Early-stage animal research may not directly benefit patients in the short term.

What this research studies

Researchers are studying how the adaptive immune system, especially Th2 cells and the cytokine IL-4, interacts with heart cells after injury to drive regeneration in newborn mice. The work builds on findings that innate immune cells alone aren’t enough and investigates whether IL-4 signaling helps cardiomyocytes proliferate and shape macrophage responses. By examining how this adaptive-innate cross-talk influences heart repair, the study aims to identify new targets that could someday improve healing after heart injury in people. The project uses neonatal mouse models and molecular analyses to map the pathways linking Th2 responses to heart cell growth and tissue regeneration.

Why it matters

Potential benefit: If successful, the research could reveal new immune-based strategies to enhance heart repair after injury in humans.

How similar studies have gone: Previous work shows immune signaling influences heart regeneration in neonatal mice, with this study exploring a less understood adaptive immune mechanism.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Olson, Eric N — University of Arizona
  • Study coordinator: Olson, Eric N

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.